BIOMAT Database Logo BIOMAT Database Logo

Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia. 1992

R J Coker, and R Nieman, and M McBride, and D M Mitchell, and J R Harris, and J N Weber

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D011020 Pneumonia, Pneumocystis A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis. P carinii Pneumonia,P. carinii Pneumonia,P. jirovecii Pneumonia,PCP Pneumonia,Pneumocystis Pneumonia,Pneumocystosis,Pneumonia, Interstitial Plasma Cell,PCP Infection,Pneumocystis carinii Pneumonia,Pneumocystis jirovecii Pneumonia,Pneumonia, Pneumocystis carinii,Infection, PCP,P carinii Pneumonias,P. carinii Pneumonias,P. jirovecii Pneumonias,PCP Infections,PCP Pneumonias,Pneumocystis Pneumonias,Pneumocystoses,Pneumonia, P carinii,Pneumonia, P. carinii,Pneumonia, P. jirovecii,Pneumonia, PCP,Pneumonia, Pneumocystis jirovecii,Pneumonias, PCP
D011739 Pyrimethamine One of the FOLIC ACID ANTAGONISTS that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis. Chloridin,Daraprim,Malocide,Tindurine
D003622 Dapsone A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) Diaminodiphenylsulfone,Sulfonyldianiline,4,4'-Diaminophenyl Sulfone,Avlosulfone,DADPS,Dapsoderm-X,Dapson-Fatol,Diaphenylsulfone,Disulone,Sulfona,4,4' Diaminophenyl Sulfone,Sulfone, 4,4'-Diaminophenyl
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte

Related Publications

R J Coker, and R Nieman, and M McBride, and D M Mitchell, and J R Harris, and J N Weber
Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
May 1991, Lancet (London, England),
R J Coker, and R Nieman, and M McBride, and D M Mitchell, and J R Harris, and J N Weber
Pentamidine or co-trimoxazole for Pneumocystis carinii pneumonia.
December 1983, Lancet (London, England),
R J Coker, and R Nieman, and M McBride, and D M Mitchell, and J R Harris, and J N Weber
Intermittent co-trimoxazole prophylaxis against Pneumocystis carinii pneumonia.
July 1990, Lancet (London, England),
R J Coker, and R Nieman, and M McBride, and D M Mitchell, and J R Harris, and J N Weber
Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
August 1996, AIDS (London, England),
R J Coker, and R Nieman, and M McBride, and D M Mitchell, and J R Harris, and J N Weber
Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease.
February 1991, Lancet (London, England),
R J Coker, and R Nieman, and M McBride, and D M Mitchell, and J R Harris, and J N Weber
Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia.
September 1992, Lancet (London, England),
R J Coker, and R Nieman, and M McBride, and D M Mitchell, and J R Harris, and J N Weber
Hepatic and pulmonary pneumocystosis during primary prophylaxis for Pneumocystis carinii pneumonia with dapsone/pyrimethamine.
January 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
R J Coker, and R Nieman, and M McBride, and D M Mitchell, and J R Harris, and J N Weber
Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.
July 1994, Antimicrobial agents and chemotherapy,
R J Coker, and R Nieman, and M McBride, and D M Mitchell, and J R Harris, and J N Weber
Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
December 1995, AIDS (London, England),
R J Coker, and R Nieman, and M McBride, and D M Mitchell, and J R Harris, and J N Weber
The safety of pyrimethamine and sulfadoxine for the prevention of Pneumocystis carinii pneumonia.
January 1997, Scandinavian journal of infectious diseases,
Copied contents to your clipboard!